down arrow

InnoCan Pharma Corp.

30
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA45783P1027
CAD
10.19
0.31 (3.14%)

Dec 04

CNQ

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
40.00
18.00
3.00
0.00
0.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
40.00
18.00
3.00
0.00
0.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
2.00
1.00
Operating Expenses
0.00
0.00
0.00
3.00
7.00
0.00
General and Administration Expenses
35.00
18.00
8.00
7.00
3.00
3.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
42.00
23.00
11.00
9.00
6.00
3.00
Operating Profit (PBDIT) excl Other Income
-1.00
-5.00
-8.00
-9.00
-6.00
-3.00
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
Operating Profit (PBDIT)
-1.00
-5.00
-8.00
-9.00
-6.00
-3.00
Interest
0.00
0.00
0.00
3.00
7.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1.00
-5.00
-5.00
-12.00
-13.00
-4.00
Provision for Tax
1.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-2.00
-6.00
-4.00
-12.00
-13.00
-4.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-0.01
-0.02
-0.02
-0.06
-0.08
-0.03
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 118.78% vs 453.29% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 66.72% vs 37.08% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 60.39% vs -29.46% in Dec 2023

Compare Profit and Loss Results of InnoCan Pharma Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
No of Months
12
12
Operating Income
40.00
35.00
5.00
14.29%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
40.00
35.00
5.00
14.29%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
8.00
-8.00
-100.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
35.00
18.00
17.00
94.44%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
42.00
26.00
16.00
61.54%
Operating Profit (PBDIT) excl Other Income
-1.00
8.00
-9.00
-112.50%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
-1.00
10.00
-11.00
-110.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
9.00
-8.00
-88.89%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
-2.00
7.00
-9.00
-128.57%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.009
0.6157
-0.62
-101.46%
Profit And Loss - Net Sales
Net Sales 40.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 118.78% vs 453.29% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 66.72% vs 37.08% in Dec 2023

Profit And Loss - Interest
Interest 0.01 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax -2.51 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 60.39% vs -29.46% in Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."